Hentschel M, Schmidt W
Zentralinstitut für Krebsforschung, Abteilung klinische Strahlenbiologie, Berlin.
Pharmazie. 1992 Mar;47(3):221-4.
For the optimal timing of application of radiosensitizers in a course of radiotherapy it is important to know the sensitizer concentration at the time of irradiation. We have studied the pharmacokinetics of the hypoxic cell sensitizer isometronidazole in man and mouse and analyzed the data on the basis of an open two-compartment model after extravasal application. The parameter estimation is performed directly to avoid estimation biasing and data points from blood and tissue compartments are approximated simultaneously. The values obtained differ significantly from the estimations calculated by other authors for the same data.
对于在放射治疗疗程中应用放射增敏剂的最佳时机而言,了解照射时增敏剂的浓度非常重要。我们研究了人及小鼠体内乏氧细胞增敏剂异甲硝唑的药代动力学,并在血管外给药后基于开放二室模型对数据进行了分析。直接进行参数估计以避免估计偏差,同时对来自血液和组织隔室的数据点进行近似处理。所得值与其他作者针对相同数据计算出的估计值有显著差异。